Haloperidol Tablet
FDA Label NDC 65841-839

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Zydus Lifesciences Limited for the product Haloperidol (NDC 65841-839). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Package Label.Principal Display Panel

NDC 65841-626-01 in bottle of 100 Tablets

Haloperidol Tablets USP, 5 mg

Rx only

100 Tablets

Haloperidol Tabs5mg (16bc834a D52d 4e98 A4e2 393452ba7e38 02)

Haloperidol Tabs5mg (16bc834a D52d 4e98 A4e2 393452ba7e38 02)

NDC 65841-627-01 in bottles of 100 tablets

Haloperidol Tablets USP, 10 mg

Rx only

100 Tablets

Haloperidol Tabs10mg (16bc834a D52d 4e98 A4e2 393452ba7e38 03)

Haloperidol Tabs10mg (16bc834a D52d 4e98 A4e2 393452ba7e38 03)

NDC 65841-628-01 in bottles of 100 tablets

Haloperidol Tablets USP, 20 mg

Rx only

100 Tablets

Haloperidol Tabs20mg (16bc834a D52d 4e98 A4e2 393452ba7e38 04)

Haloperidol Tabs20mg (16bc834a D52d 4e98 A4e2 393452ba7e38 04)

* Please review the disclaimer below.